After a number of conflicting studies on whether extra weight is harmful to bone health, the latest research appears to weigh in on the affirmative. A University of Georgia study in the Journal of Clinical nutrition indicates that the bones of women with high body fat were weaker than those with normal body fat. This appears to contradict... Read more
A new study in the New England of Journal indicates that teriparatide (brand name Forteo) may be more effective in building bone than alendronate (Fosamax). The University of Alabama study, conducted on 428 women and men whose osteoporosis was induced by long-term use of glucocorticoid medicines such as Prednisone, also showed a bigger... Read more
There is new research in the Journal of Bone and Mineral Research that the process of single-energy vertebral fracture assessment (VFA), used to detect potential compression fractures in the spine, can also provide information on the possibility of stroke or heart attacks in the patient. Physicians may be able to use the scan to look for... Read more
Zoledronic acid, a once-yearly infusion, has been approved by Health Canada for treatment of postmenopausal osteoporosis. Known as Reclast in the U.S., the bisphosphonate medication received FDA approval for that purpose just a few months ago. It will be sold as Aclasta in Canada and will help provide osteoporosis patients in the country one more... Read more
A new article in the International Journal of Clinical Practice indicates that osteoporosis is infrequent among women under 65, even among those who break their forearm. While DXA bone scans (the most definitive test that screens for osteoporosis) are routinely recommended for women older than 65 and for those who have other risk factors (a... Read more